Lansoprazole Tablet, Orally Disintegrating, Delayed Release
Product Images NDC 55154-8340

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 55154-8340). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30mg Bag Label (7daa1721 F92b 4096 B19e 4d27fc8acb51 00)

Lansoprazole delayed-release orally disintegrating tablets, 30 mg, in a 10-tablet unit-dose package labeled by Cardinal Health 107, LLC. The label includes storage instructions, a warning that the unit dose is not child-resistant and intended for institutional use, pharmacist instructions for administration, and distributor information for Aurobindo Pharma USA and Cardinal Health.*

FDA Label Image

Figure1 (Lansoprazole Fig1)

A line graph titled 'Mean Severity of Day Heartburn By Study Day For Evaluable Patients.' The graph shows mean severity of day heartburn (scale 0-3) on the vertical axis and days from start of treatment on the horizontal axis (-5 to 60). It compares placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD, showing trends in heartburn severity across the treatment period.*

FDA Label Image

Figure2 (Lansoprazole Fig2)

A line graph titled 'Mean Severity of Night Heartburn By Study Day For Evaluable Patients' showing mean severity scores (0 to 3) versus study days from -5 to 60. The graph compares three groups: Placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD, indicating changes in night heartburn severity over time during treatment.*

FDA Label Image

Chemical Structure (Lansoprazole Str)

Chemical structure diagram of Lansoprazole, showing the molecular arrangement of atoms including benzene and pyridine rings, with sulfoxide and trifluoromethoxy functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.